[Various cellular immunity indices in patients with esophageal cancer].
It was found that 75.8% of patients with esophageal cancer respond positively to percutaneous injection of the antigen polysaccharid fraction. In patients with esophagitis the positive reaction was noted in 25% of cases. The rosette-forming capacity of lymphocytes is suppressed in 91.2% of patients with esophageal cancer. Chemoradiation treatment results in greater depression of the organism responsiveness than chemotherapy.
D000951:Antigens, Neoplasm / Q000276:immunology; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D012882:Skin Tests
D000951:Antigens, Neoplasm
Nekotorye pokazateli kletochnogo immuniteta u bol'nykh rakom pishchevoda.